PCM
GILD icon

Palouse Capital Management’s Gilead Sciences GILD Stock Holding History

Palouse Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,536
Closed -$3.06M – 88
2022
Q1 		$3.06M Buy
51,536
+1,303
+3% +$83.3K 1.35% 32
2021
Q4 		$3.65M Sell
50,233
-1,078
-2% -$74.2K 1.56% 22
2021
Q3 		$3.58M Sell
51,311
-1,296
-2% -$91K 1.59% 20
2021
Q2 		$3.62M Sell
52,607
-444
-0.8% -$29.6K 1.58% 21
2021
Q1 		$3.43M Sell
53,051
-1,602
-3% -$103K 1.51% 28
2020
Q4 		$3.18M Sell
54,653
-32,153
-37% -$1.94M 1.69% 24
2020
Q3 		$5.49M Buy
86,806
+8,315
+11% +$577K 3.07% 3
2020
Q2 		$6.04M Sell
78,491
-3,213
-4% -$246K 3.19% 3
2020
Q1 		$6.11M Buy
81,704
+3,623
+5% +$250K 3.61% 2
2019
Q4 		$5.07M Sell
78,081
-12,404
-14% -$808K 1.92% 26
2019
Q3 		$5.74M Sell
90,485
-1,322
-1% -$86.4K 2.13% 18
2019
Q2 		$6.2M Sell
91,807
-1,096
-1% -$72.1K 2.23% 14
2019
Q1 		$6.04M Buy
92,903
+10,619
+13% +$706K 2.32% 12
2018
Q4 		$5.15M Sell
82,284
-10,214
-11% -$714K 2.03% 20
2018
Q3 		$7.14M Buy
92,498
+456
+0.5% +$34.4K 2.5% 6
2018
Q2 		$6.52M Sell
92,042
-1,331
-1% -$94K 2.21% 10
2018
Q1 		$7.04M Buy
93,373
+302
+0.3% +$24K 2.34% 8
2017
Q4 		$6.67M Buy
93,071
+511
+0.6% +$38.8K 2.25% 9
2017
Q3 		$7.5M Sell
92,560
-783
-0.8% -$59.9K 2.51% 5
2017
Q2 		$6.61M Sell
93,343
-392
-0.4% -$26.1K 2.4% 8
2017
Q1 		$6.37M Buy
93,735
+52,339
+126% +$3.68M 2.42% 8
2016
Q4 		$2.96M Sell
41,396
-5,850
-12% -$435K 1.21% 40
2016
Q3 		$3.74M Sell
47,246
-2,948
-6% -$239K 1.59% 27
2016
Q2 		$4.19M Buy
50,194
+11,890
+31% +$1.06M 1.7% 24
2016
Q1 		$3.52M Buy
+38,304
New +$3.45M 1.44% 31

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palouse Capital Management's GILD Position: Q2 2022 in Review

Palouse Capital Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 51,536 shares — an estimated $3.06M sold.

Palouse Capital Management first reported a position in GILD in Q1 2016 and held it in 25 quarters. The position peaked at $7.5M in Q3 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Palouse Capital Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Palouse Capital Management sold 51,536 Gilead Sciences shares in Q2 2022, an estimated $3.06M.
  • Palouse Capital Management first reported a position in Gilead Sciences in Q1 2016 and held it in 25 quarters.
  • Palouse Capital Management's Gilead Sciences position peaked at $7.5M in Q3 2017.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Palouse Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.